This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Original paper

Overcoming presynaptic effects of VAMP2 mutations with 4‐aminopyridine treatment

Volume: 41, Issue: 11, Pages: 1999 - 2011
Published: Oct 1, 2020
Abstract
Clinical and genetic features of five unrelated patients with de novo pathogenic variants in the synaptic vesicle-associated membrane protein 2 (VAMP2) reveal common features of global developmental delay, autistic tendencies, behavioral disturbances, and a higher propensity to develop epilepsy. For one patient, a cognitively impaired adolescent with a de novo stop-gain VAMP2 mutation, we tested a potential treatment strategy, enhancing...
Paper Details
Title
Overcoming presynaptic effects of VAMP2 mutations with 4‐aminopyridine treatment
Published Date
Oct 1, 2020
Volume
41
Issue
11
Pages
1999 - 2011
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.